BioCentury | Apr 15, 2021
Regulation

April 14 Quick Takes: GSK stops two trials of ICOS agonist; plus Trodelvy, Amylyx, Junshi, Jazz, MitoChem

...aging diseases by focusing on protecting mitochondrial homeostasis. It received its early funding from the Foundation Fighting Blindness...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...to treat Leber congenital amaurosis 1. Joining Sofinnova were Abingworth, Lightstone Ventures, Hatteras Venture Partners, the Foundation Fighting Blindness’...
BioCentury | Oct 30, 2020
Deals

Via takeout of Atlas-grown optogenetic play for $150M up front, Novartis adds to gene therapy arsenal

...2019 with $21 million in a series A round from Atlas Venture, Mission BioCapital and the Foundation Fighting Blindness’...
...as Vedere, retains its predecessor’s management and will be backed by Atlas Venture, Mission BioCapital and the Foundation Fighting Blindness.“The...
BioCentury | Oct 24, 2020
Emerging Company Profile

SparingVision’s line of sight to a mutation-agnostic gene therapy for ophthalmic disease

...from Jeito Capital, Ysios Capital, Bpifrance and Foundation Fighting Blindness...
...€60 million ($69.2 million)Investors: 4BIO Capital, Bpifrance, Foundation Fighting Blindness...
BioCentury | Jul 30, 2020
Finance

July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

...vector delivering GUCY2D with financial support from Sanofi’s Genzyme unit. Hatteras Venture Partners and the Foundation Fighting Blindness’...
BioCentury | Mar 7, 2018
Translation in Brief

Beyond PAM

...system in retinal and non-retinal human cell lines. Brian Mansfield, deputy chief research officer at Foundation Fighting Blindness...
BioCentury | Dec 12, 2017
Company News

Management tracks: Achaogen, Minerva

...as CEO. She was chief drug development officer of the clinical research institute division of Foundation Fighting Blindness...
BioCentury | Oct 20, 2017
Regulation

Patients in focus

...2011 advisory committee. “FDA is really going the route of listening to individuals.” Stephen Rose, Foundation Fighting Blindness...
...clinical outcomes assessment tools such as patient-reported outcomes (PROs). Stephen Rose, chief research officer at Foundation Fighting Blindness...
...to individuals,” Rose said. Luxturna has a Jan. 12 PDUFA date. Companies and Institutions Mentioned Foundation Fighting Blindness...
BioCentury | Sep 1, 2017
Company News

AGTC and the FFB partner to advance opthalmic research

...Applied Genetics Technology Corp. (NASDAQ:AGTC) provided The Foundation Fighting Blindness Inc. (Columbia, Md.) an undisclosed grant which the...
...Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Foundation Fighting Blindness Inc. , Columbia, Md. Business: Ophthalmic Shannon Lehnbeuter XLRP Applied Genetic Technologies Corp. Foundation Fighting Blindness...
BioCentury | Dec 14, 2015
Company News

Case Western Reserve University, Vision Medicines deal

...testing for Stargardt disease. Vision plans to start a Phase I/II trial next year. The Foundation Fighting Blindness...
Items per page:
1 - 10 of 19
BioCentury | Apr 15, 2021
Regulation

April 14 Quick Takes: GSK stops two trials of ICOS agonist; plus Trodelvy, Amylyx, Junshi, Jazz, MitoChem

...aging diseases by focusing on protecting mitochondrial homeostasis. It received its early funding from the Foundation Fighting Blindness...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...to treat Leber congenital amaurosis 1. Joining Sofinnova were Abingworth, Lightstone Ventures, Hatteras Venture Partners, the Foundation Fighting Blindness’...
BioCentury | Oct 30, 2020
Deals

Via takeout of Atlas-grown optogenetic play for $150M up front, Novartis adds to gene therapy arsenal

...2019 with $21 million in a series A round from Atlas Venture, Mission BioCapital and the Foundation Fighting Blindness’...
...as Vedere, retains its predecessor’s management and will be backed by Atlas Venture, Mission BioCapital and the Foundation Fighting Blindness.“The...
BioCentury | Oct 24, 2020
Emerging Company Profile

SparingVision’s line of sight to a mutation-agnostic gene therapy for ophthalmic disease

...from Jeito Capital, Ysios Capital, Bpifrance and Foundation Fighting Blindness...
...€60 million ($69.2 million)Investors: 4BIO Capital, Bpifrance, Foundation Fighting Blindness...
BioCentury | Jul 30, 2020
Finance

July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

...vector delivering GUCY2D with financial support from Sanofi’s Genzyme unit. Hatteras Venture Partners and the Foundation Fighting Blindness’...
BioCentury | Mar 7, 2018
Translation in Brief

Beyond PAM

...system in retinal and non-retinal human cell lines. Brian Mansfield, deputy chief research officer at Foundation Fighting Blindness...
BioCentury | Dec 12, 2017
Company News

Management tracks: Achaogen, Minerva

...as CEO. She was chief drug development officer of the clinical research institute division of Foundation Fighting Blindness...
BioCentury | Oct 20, 2017
Regulation

Patients in focus

...2011 advisory committee. “FDA is really going the route of listening to individuals.” Stephen Rose, Foundation Fighting Blindness...
...clinical outcomes assessment tools such as patient-reported outcomes (PROs). Stephen Rose, chief research officer at Foundation Fighting Blindness...
...to individuals,” Rose said. Luxturna has a Jan. 12 PDUFA date. Companies and Institutions Mentioned Foundation Fighting Blindness...
BioCentury | Sep 1, 2017
Company News

AGTC and the FFB partner to advance opthalmic research

...Applied Genetics Technology Corp. (NASDAQ:AGTC) provided The Foundation Fighting Blindness Inc. (Columbia, Md.) an undisclosed grant which the...
...Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Foundation Fighting Blindness Inc. , Columbia, Md. Business: Ophthalmic Shannon Lehnbeuter XLRP Applied Genetic Technologies Corp. Foundation Fighting Blindness...
BioCentury | Dec 14, 2015
Company News

Case Western Reserve University, Vision Medicines deal

...testing for Stargardt disease. Vision plans to start a Phase I/II trial next year. The Foundation Fighting Blindness...
Items per page:
1 - 10 of 19